MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
CONMED Corporation Cash Conversion Cycle 2011-2026 | CNMD
Annual Cash Conversion Cycle CONMED Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 212 | 218 | 221 | 232 | 195 | 191 | 164 | 172 | 176 | 168 | 212 | 200 | 190 | 200 | 222 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 232 | 164 | 198 |
Quarterly Cash Conversion Cycle CONMED Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 200 | 215 | 222 | 220 | 202 | 220 | 233 | 221 | 231 | - | 118 | 97.9 | 223 | - | 206 | 182 | 195 | 63.9 | 192 | 253 | 198 | 65.2 | 170 | 165 | 176 | 68.3 | 183 | 173 | 178 | 68.5 | 184 | 175 | 179 | 66.3 | 176 | 164 | 176 | 64 | 232 | 205 | 204 | 60.5 | 212 | 193 | 206 | 63 | 197 | 184 | 203 | 63.1 | 214 | 201 | 201 | 66.7 | 237 | 214 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 253 | 60.5 | 172 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
-61.8 | $ 2.21 | - | $ 3.45 M |  USA |
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
20.1 | $ 10.39 | -0.62 % | $ 1.4 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
240 | $ 12.99 | -0.46 % | $ 1.95 B | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
-4.41 | $ 8.26 | -1.2 % | $ 593 M |  Israel |
 |
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | USA |
 |
ClearPoint Neuro
CLPT
|
217 | $ 9.56 | -14.34 % | $ 271 M | USA |
 |
Butterfly Network
BFLY
|
815 | $ 4.08 | -4.23 % | $ 864 M | USA |
 |
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
107 | $ 70.52 | -1.02 % | $ 104 B | USA |
 |
Cytosorbents Corporation
CTSO
|
50.6 | $ 0.66 | -2.96 % | $ 35.9 M | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 3.98 | -1.85 % | $ 148 M |  France |
 |
Establishment Labs Holdings
ESTA
|
339 | $ 64.59 | -0.65 % | $ 1.91 B |  Costa-rica |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
234 | $ 18.43 | -0.11 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | USA |
 |
Abbott Laboratories
ABT
|
101 | $ 109.14 | -1.45 % | $ 190 B | USA |
 |
InMode Ltd.
INMD
|
234 | $ 13.56 | -0.66 % | $ 876 M | Israel |
 |
Delcath Systems
DCTH
|
258 | $ 9.5 | -2.44 % | $ 340 M | USA |
 |
IRIDEX Corporation
IRIX
|
119 | $ 1.33 | - | $ 21.5 M | USA |
 |
Bio-Rad Laboratories
BIO
|
263 | $ 267.52 | -0.69 % | $ 7.55 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
714 | $ 16.83 | -2.21 % | $ 395 M | USA |
 |
Helius Medical Technologies
HSDT
|
18.2 | $ 2.07 | -4.84 % | $ 1.26 M | USA |
 |
AxoGen
AXGN
|
245 | $ 31.67 | -3.3 % | $ 1.46 B | USA |
 |
Align Technology
ALGN
|
137 | $ 170.8 | -3.02 % | $ 12.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 8.85 | -2.75 % | $ 682 M | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 33.42 | -0.95 % | $ 4.98 K | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
208 | $ 3.84 | 2.67 % | $ 158 M | USA |
 |
Second Sight Medical Products
EYES
|
-21 | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
184 | $ 0.38 | -2.91 % | $ 39.1 M | USA |
 |
IRadimed Corporation
IRMD
|
224 | $ 102.83 | 0.03 % | $ 1.31 B | USA |